Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance in Cirrhotic Patients With Vasodilatory Shock: A Prospective, Randomized Controlled Trial

NCT07568275 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT07568275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07568275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance in Cirrhotic Patients With Vasodilatory Shock: A Prospective, Randomized Controlled Trial
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 15, 2024
Completion date
January 31, 2028
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cirrhosis, septic shock, vasodilatory shock